Form 4: Liquidia Corp's Chief Medical Officer Rajeev Saggar Reports Sale of Shares to Cover Taxes

Rajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling shares to cover taxes associated with the vesting of restricted stock units.

Summary

• On April 14, 2025, Rajeev Saggar, the Chief Medical Officer of Liquidia Corp, sold 3,714 shares of common stock at a price of $13.57 per share.
• The sale was executed to cover taxes associated with the settlement of restricted stock units (RSUs) that vested on the same date.
• Following the transaction, Saggar directly owns 265,602 shares of Liquidia Corp, which includes unvested RSUs and shares acquired through the Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock transactions, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations upon RSU vesting are a common practice across publicly traded companies.
• Comparable companies such as United Therapeutics or Acceleron Pharma also see similar filings from their executives.
• The volume of shares sold and the remaining ownership stake are within typical ranges for executive compensation packages in the biotech industry.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, as it is a routine sale of shares by an executive.
• The sale does not indicate any change in the company's fundamentals or outlook.

Key Dates

Keywords

Liquidia Corp, Rajeev Saggar, Form 4, Share Sale, Restricted Stock Units, RSUs, Beneficial Ownership, Officer, LQDA, Taxes